Cargando…

Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration

Peroxisome proliferator-activated receptors (PPARs) activity has significant implications for the development of novel therapeutic modalities against neurodegenerative diseases. Although PPAR-α, PPAR-β/δ, and PPAR-γ nuclear receptor expressions are significantly reported in the brain, their implicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Durai, Priya, Beeraka, Narasimha M., Ramachandrappa, Hemanth Vikram Poola, Krishnan, Prakash, Gudur, Pranesh, Raghavendra, Nulgumnalli Manjunathaiah, Ravanappa, Prashantha Kumar Bommenahally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881103/
https://www.ncbi.nlm.nih.gov/pubmed/34751120
http://dx.doi.org/10.2174/1570159X19666211109141330
_version_ 1784879041616019456
author Durai, Priya
Beeraka, Narasimha M.
Ramachandrappa, Hemanth Vikram Poola
Krishnan, Prakash
Gudur, Pranesh
Raghavendra, Nulgumnalli Manjunathaiah
Ravanappa, Prashantha Kumar Bommenahally
author_facet Durai, Priya
Beeraka, Narasimha M.
Ramachandrappa, Hemanth Vikram Poola
Krishnan, Prakash
Gudur, Pranesh
Raghavendra, Nulgumnalli Manjunathaiah
Ravanappa, Prashantha Kumar Bommenahally
author_sort Durai, Priya
collection PubMed
description Peroxisome proliferator-activated receptors (PPARs) activity has significant implications for the development of novel therapeutic modalities against neurodegenerative diseases. Although PPAR-α, PPAR-β/δ, and PPAR-γ nuclear receptor expressions are significantly reported in the brain, their implications in brain physiology and other neurodegenerative diseases still require extensive studies. PPAR signaling can modulate various cell signaling mechanisms involved in the cells contributing to on- and off-target actions selectively to promote therapeutic effects as well as the adverse effects of PPAR ligands. Both natural and synthetic ligands for the PPARα, PPARγ, and PPARβ/δ have been reported. PPARα (WY 14.643) and PPARγ agonists can confer neuroprotection by modulating mitochondrial dynamics through the redox system. The pharmacological effect of these agonists may deliver effective clinical responses by protecting vulnerable neurons from Aβ toxicity in Alzheimer’s disease (AD) patients. Therefore, the current review delineated the ligands’ interaction with 3D-PPARs to modulate neuroprotection, and also deciphered the efficacy of numerous drugs, viz. Aβ aggregation inhibitors, vaccines, and γ-secretase inhibitors against AD; this review elucidated the role of PPAR and their receptor isoforms in neural systems, and neurodegeneration in human beings. Further, we have substantially discussed the efficacy of PPREs as potent transcription factors in the brain, and the role of PPAR agonists in neurotransmission, PPAR gamma coactivator-1α (PGC-1α) and mitochondrial dynamics in neuroprotection during AD conditions. This review concludes with the statement that the development of novel PPARs agonists may benefit patients with neurodegeneration, mainly AD patients, which may help mitigate the pathophysiology of dementia, subsequently improving overall the patient’s quality of life.
format Online
Article
Text
id pubmed-9881103
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-98811032023-02-09 Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration Durai, Priya Beeraka, Narasimha M. Ramachandrappa, Hemanth Vikram Poola Krishnan, Prakash Gudur, Pranesh Raghavendra, Nulgumnalli Manjunathaiah Ravanappa, Prashantha Kumar Bommenahally Curr Neuropharmacol Neurology Peroxisome proliferator-activated receptors (PPARs) activity has significant implications for the development of novel therapeutic modalities against neurodegenerative diseases. Although PPAR-α, PPAR-β/δ, and PPAR-γ nuclear receptor expressions are significantly reported in the brain, their implications in brain physiology and other neurodegenerative diseases still require extensive studies. PPAR signaling can modulate various cell signaling mechanisms involved in the cells contributing to on- and off-target actions selectively to promote therapeutic effects as well as the adverse effects of PPAR ligands. Both natural and synthetic ligands for the PPARα, PPARγ, and PPARβ/δ have been reported. PPARα (WY 14.643) and PPARγ agonists can confer neuroprotection by modulating mitochondrial dynamics through the redox system. The pharmacological effect of these agonists may deliver effective clinical responses by protecting vulnerable neurons from Aβ toxicity in Alzheimer’s disease (AD) patients. Therefore, the current review delineated the ligands’ interaction with 3D-PPARs to modulate neuroprotection, and also deciphered the efficacy of numerous drugs, viz. Aβ aggregation inhibitors, vaccines, and γ-secretase inhibitors against AD; this review elucidated the role of PPAR and their receptor isoforms in neural systems, and neurodegeneration in human beings. Further, we have substantially discussed the efficacy of PPREs as potent transcription factors in the brain, and the role of PPAR agonists in neurotransmission, PPAR gamma coactivator-1α (PGC-1α) and mitochondrial dynamics in neuroprotection during AD conditions. This review concludes with the statement that the development of novel PPARs agonists may benefit patients with neurodegeneration, mainly AD patients, which may help mitigate the pathophysiology of dementia, subsequently improving overall the patient’s quality of life. Bentham Science Publishers 2022-04-18 2022-04-18 /pmc/articles/PMC9881103/ /pubmed/34751120 http://dx.doi.org/10.2174/1570159X19666211109141330 Text en © 2022 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Neurology
Durai, Priya
Beeraka, Narasimha M.
Ramachandrappa, Hemanth Vikram Poola
Krishnan, Prakash
Gudur, Pranesh
Raghavendra, Nulgumnalli Manjunathaiah
Ravanappa, Prashantha Kumar Bommenahally
Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration
title Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration
title_full Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration
title_fullStr Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration
title_full_unstemmed Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration
title_short Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration
title_sort advances in ppars molecular dynamics and glitazones as a repurposing therapeutic strategy through mitochondrial redox dynamics against neurodegeneration
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881103/
https://www.ncbi.nlm.nih.gov/pubmed/34751120
http://dx.doi.org/10.2174/1570159X19666211109141330
work_keys_str_mv AT duraipriya advancesinpparsmoleculardynamicsandglitazonesasarepurposingtherapeuticstrategythroughmitochondrialredoxdynamicsagainstneurodegeneration
AT beerakanarasimham advancesinpparsmoleculardynamicsandglitazonesasarepurposingtherapeuticstrategythroughmitochondrialredoxdynamicsagainstneurodegeneration
AT ramachandrappahemanthvikrampoola advancesinpparsmoleculardynamicsandglitazonesasarepurposingtherapeuticstrategythroughmitochondrialredoxdynamicsagainstneurodegeneration
AT krishnanprakash advancesinpparsmoleculardynamicsandglitazonesasarepurposingtherapeuticstrategythroughmitochondrialredoxdynamicsagainstneurodegeneration
AT gudurpranesh advancesinpparsmoleculardynamicsandglitazonesasarepurposingtherapeuticstrategythroughmitochondrialredoxdynamicsagainstneurodegeneration
AT raghavendranulgumnallimanjunathaiah advancesinpparsmoleculardynamicsandglitazonesasarepurposingtherapeuticstrategythroughmitochondrialredoxdynamicsagainstneurodegeneration
AT ravanappaprashanthakumarbommenahally advancesinpparsmoleculardynamicsandglitazonesasarepurposingtherapeuticstrategythroughmitochondrialredoxdynamicsagainstneurodegeneration